Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Disease

Donanemab is not a cure and comes with significant side effects, but patients had longer periods of independent living while on the drug.

from NYT > Top Stories https://ift.tt/bWljJ3M
via IFTTT